Archives by Month:
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- January 2024
- December 2023
- November 2023
- October 2023
- August 2023
- July 2023
- June 2023
- May 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- July 2016
- June 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- November 2012
- October 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- June 2009
- April 2009
- February 2009
- December 2008
- November 2008
- October 2008
- August 2008
- June 2008
- May 2008
Archives by Year:
Does The Mexican Peso Have Further To Fall?
Historic Devaluation The Mexican Peso has been under significant pressure over the last year, and the current level of devaluation in the currency is historic in both nominal and real terms.In the first 8 trading days of 2017, the Peso lost just under 14% of its value against the US Dollar. The sell -off, which […]
Dollar Is Firmer, But Mostly Sidelined, As Equity Charge Continues
The US dollar is mostly firmer against the major currencies but is confined to narrow ranges, and well-worn ranges at that, but the focus has shifted to the strong advance in equities. Yesterday, the Dow Jones Industrials finally rose through the psychologically-important 20k level, and the S&P 500 gapped higher to new record levels. The […]
Crude Oil Prices Mark Time As All Eyes Stay On The White House
Crude oil prices continue to mark time in familiar territory. A larger-than-expected inventory build reported by the EIA applied a bit of selling pressure but failed to push prices out of recent ranges. The data showed stockpiles added 2.84 million barrels last week, much more than the 1.47mb gain projected by economists. Gold prices declined as US Treasury bond […]
Softer Growth Expected For Tomorrow’s US Q4 GDP Report
US economic growth is widely expected to decelerate in tomorrow’s “advance” GDP release for the fourth quarter after a strong increase in Q3. Most forecasters see output rising in the low-2% range, roughly unchanged from last month’s review and well below the robust 3.5% expansion in Q3 (based on the seasonally adjusted annual rate). The Wall Street […]
Global Stock Index On Verge Of All-Time High Propelled By “Dow 20,000” Euphoria
With global stock markets basking in the afterglow of Dow crossing 20,000 for the first time, on Thursday they propelled higher in sympathy with the US, as Asia and Europe are trading solidly in the green, as is the dollar which rebounded strongly off a 5 week low. Copper touched the highest price since November […]
3 Things: Inflation, Stocks Vs. Bonds & Everyone’s A Genius
Another View On The Inflation Argument There is little evidence that current levels of inflation are stable. As I wrote in “Inflation: The Good & The Bad”, outside of just two areas, rent and health care, there remains a broader deflationary trend currently. Importantly, as I noted, there are two types of inflation: “Inflationary pressures can […]
Dollar Shaky On Trump Decisions
Though recovering now, the US Dollar continues to be shaky and earlier struck a 7-week trough as concerns grow over a perceived protectionist stance by the US President. Yesterday, President Trump gave the green light to begin construction on a wall to separate the southern border of the United States and Mexico in an effort […]
Oil And Petroleum Product Inventories Worse Than Last Year
We examine the EIA Data this past week, and it is interesting what a difference a year makes psychologically speaking as we have more inventories in storage across the board yet we are almost double the oil price versus this time last year in $53 a barrel versus $26 a barrel. There is a lot […]
Gold Slips As Stocks Surge
Gold prices ended Wednesday’s session down $8.85 as a renewed appetite for riskier assets pushed market players to lock in profits and roll their funds into equities. The Dow Jones Industrial Average closed above 20000 for the first time, the S&P 500 rose 0.8% and the Nasdaq Composite gained 0.99% while the dollar index fell […]
Johnson & Johnson Acquires European Biotech Giant Actelion For $30 Billion
Concluding weeks of speculation, overnight Johnson & Johnson (JNJ) announced it agreed to acquire Actelion Pharmaceuticals (ALIOF), Europe’s biggest biotech company, for $30 billion, or CHF280 per share, expanding the U.S. pharma giant’s portfolio of rare-disease treatments as its top-selling drug faces new competition. The deal, announced and agreed on Thursday by both companies, ends […]
